Press releaseGlobe Newswire
iBio
IBIO · NYSE American
$0.821+$0.0609 (+8.01%)TodayMarket closed ·
Prev close $0.7601
Latest news
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
- Press releaseGlobe Newswire
iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
- Press releaseGlobe Newswire
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
- Press releaseGlobe Newswire
iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
- Press releaseGlobe Newswire
iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors
- News
iBio Gets Australian Regulatory Clearance For First-In-Human Phase 1 Trial Of IBIO-600, A Long-Acting Anti-Myostatin Antibody Targeting Muscle Loss In Obesity
- Press releaseGlobe Newswire
iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia
- Press releaseGlobe Newswire
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
- News
iBio Earnings Review: Q2 Summary
- Press releaseGlobe Newswire
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings
- Press releaseGlobe Newswire
iBio Announces Closing of $50 Million Public Offering
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseGlobe Newswire
iBio Announces Pricing of $50 Million Public Offering
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
- NewsRishabh Mishra
US Stocks Likely To Open Higher After Trump Announces Iran-Israel Ceasefire: FedEx, TD Synnex In Focus Ahead Of Earnings
- News
ibio Announces It Will Host Conference Call On Tuesday, June 24, At 8:30 A.M. EST To Review Its Latest Advances In Obesity And Cardiometabolic Disease Treatments And Announce A Third Target In The Astralbio Collaboration In Addition To Myostatin And Activin E
- Press releaseGlobe Newswire
iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releaseGlobe Newswire
iBio Reports Fiscal Third Quarter 2025 Financial Results
- Press releaseGlobe Newswire
iBio Reports Fiscal Second Quarter 2025 Financial Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.